Complementary and Alternative Medicine Use and Quality of Life in Patients with Primary Brain Tumors

Journal of Pain and Symptom Management

Volumn 32, Issue 2, 2006, Pages 148-154

  Armstrong, Terri ^a   Cohen, Marlene Z ^a   Hess, Kenneth R ^a   Manning, Rochelle ^a   Lee, Eva Lu T ^a   Tamayo, Geline ^a   Baumgartner, Karen ^a   Min, Sur J ^a   Yung, Alfred ^a   Gilbert, Mark ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

brain tumors; complementary medicine; Quality of life

Indexed keywords

ADULT; AGED; ALTERNATIVE MEDICINE; ARTICLE; BRAIN TUMOR; COST BENEFIT ANALYSIS; DATA ANALYSIS; DEMOGRAPHY; FEMALE; HEALTH CARE COST; HERBAL MEDICINE; HUMAN; MALE; QUALITY OF LIFE; RELIGION; SPIRITUAL HEALING; TEA; VITAMIN SUPPLEMENTATION;

ADULT; AGE DISTRIBUTION; AGED; BRAIN NEOPLASMS; COMPLEMENTARY THERAPIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PALLIATIVE CARE; QUALITY OF LIFE; RISK ASSESSMENT; RISK FACTORS; SEX DISTRIBUTION; TEXAS; TREATMENT OUTCOME;

EID: 33746297056     PISSN: 08853924     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpainsymman.2006.02.015     Document Type: Article

References (29)

1. Eisenberg D.M., Davis R.B., Ettner S.L., et al. Trends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey. JAMA 280 18 (1998) 1569-1575
2. Lee M.M., Chang J.S., Jacobs B., and Wrensch M.R. Complementary and alternative medicine use among men with prostate cancer in 4 ethnic populations. Am J Public Health 92 10 (2002) 1606-1609
3. Sparber A., Wootton J.C., Bauer L., et al. Use of complementary medicine by adult patients participating in HIV/AIDS clinical trials. J Altern Complement Med 6 5 (2000) 415-422
4. Lerner I.J., and Kennedy B.J. The prevalence of questionable methods of cancer treatment in the United States. CA Cancer J Clin 42 3 (1992) 181-191
5. Cassileth B.R., Lusk E.J., Strouse T.B., and Bodenheimer B.J. Contemporary unorthodox treatments in cancer medicine. A study of patients, treatments, and practitioners. Ann Intern Med 101 1 (1984) 105-112
6. Astin J.A. Why patients use alternative medicine: results of a national study. JAMA 279 19 (1998) 1548-1553
7. Coss R.A., McGrath P., and Caggiano V. Alternative care. Patient choices for adjunct therapies within a cancer center. Cancer Pract 6 3 (1998) 176-181
8. Eisenberg D.M., Kessler R.C., Foster C., et al. Unconventional medicine in the United States. Prevalence, costs, and patterns of use. N Engl J Med 328 4 (1993) 246-252
9. Elder N.C., Gillcrist A., and Minz R. Use of alternative health care by family practice patients. Arch Fam Med 6 2 (1997) 181-184
10. Bennett M., and Lengacher C. Use of complementary therapies in a rural cancer population. Oncol Nurs Forum 26 8 (1999) 1287-1294
11. Miller M., Boyer M.J., Butow P.N., et al. The use of unproven methods of treatment by cancer patients. Frequency, expectations and cost. Support Care Cancer 6 4 (1998) 337-347
12. Richardson M.A., Sanders T., Palmer J.L., Greisinger A., and Singletary S.E. Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology. J Clin Oncol 18 13 (2000) 2505-2514
13. Sollner W., Zingg-Schir M., Rumpold G., and Fritsch P. Attitude toward alternative therapy, compliance with standard treatment, and need for emotional support in patients with melanoma. Arch Dermatol 133 3 (1997) 316-321
14. Warrick P.D., Irish J.C., Morningstar M., Gilbert R., Brown D., and Gullane P. Use of alternative medicine among patients with head and neck cancer. Arch Otolaryngol Head Neck Surg 125 5 (1999) 573-579
15. Nam R.K., Fleshner N., Rakovitch E., et al. Prevalence and patterns of the use of complementary therapies among prostate cancer patients: an epidemiological analysis. J Urol 161 5 (1999) 1521-1524
16. Morris K.T., Johnson N., Homer L., and Walts D. A comparison of complementary therapy use between breast cancer patients and patients with other primary tumor sites. Am J Surg 179 5 (2000) 407-411
17. Verhoef M.J., Hagen N., Pelletier G., and Forsyth P. Alternative therapy use in neurologic diseases: use in brain tumor patients. Neurology 52 3 (1999) 617-622
18. Fox S.W., et al. Predictors of complementary and alternative medicine practices and products use in patients with malignant glioma: re-analysis of the glioma outcomes project database. Neuro-Oncology 5 4 (2003) 332
19. Cella D.F., Tulsky D.S., Gray G., et al. The Functional Assessment of Cancer Therapy scale: development and validation of the general measure. J Clin Oncol 11 3 (1993) 570-579
20. Weitzner M.A., Meyers C.A., Gelke C.K., et al. The Functional Assessment of Cancer Therapy (FACT) scale. Development of a brain subscale and revalidation of the general version (FACT-G) in patients with primary brain tumors. Cancer 75 5 (1995) 1151-1161
21. Markowitz J.S., Donovan J.L., DeVane C.L., et al. Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme. JAMA 290 11 (2003) 1500-1504
22. Chang S.M., Kuhn J.G., Rizzo J., et al. Phase I study of paclitaxel in patients with recurrent malignant glioma: a North American Brain Tumor Consortium report. J Clin Oncol 16 6 (1998) 2188-2194
23. Armstrong T.S. Harvesting hope in the autumn of life: a review of quality of life in central nervous system tumors. Clin J Oncol Nurs 3 1 (1999) 23-28
24. Lieberman A.N., Foo S.H., Ransohoff J., et al. Long term survival among patients with malignant brain tumors. Neurosurgery 10 4 (1982) 450-453
25. Hochberg F.H., Linggood R., Wolfson L., Baker W.H., and Kornblith P. Quality and duration of survival in glioblastoma multiforme. Combined surgical, radiation, and lomustine therapy. JAMA 241 10 (1979) 1016-1018
26. Sachsenheimer W., Piotrowski W., and Bimmler T. Quality of life in patients with intracranial tumors on the basis of Karnofsky's performance status. J Neurooncol 13 2 (1992) 177-181
27. Mackworth N., Fobair P., and Prados M.D. Quality of life self-reports from 200 brain tumor patients: comparisons with Karnofsky performance scores. J Neurooncol 14 3 (1992) 243-253
28. Leibel S.A., Gutin P.H., Wara W.M., et al. Survival and quality of life after interstitial implantation of removable high-activity iodine-125 sources for the treatment of patients with recurrent malignant gliomas. Int J Radiat Oncol Biol Phys 17 6 (1989) 1129-1139
29. Tasaki K., Maskarinec G., Shumay D.M., Tatsumura Y., and Kakai H. Communication between physicians and cancer patients about complementary and alternative medicine: exploring patients' perspectives. Psychooncology 11 3 (2002) 212-220